Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Terry Nolan
Antibody Persistence in Australian Adolescents Following Meningococcal C Conjugate Vaccination
Pediatric Infectious Disease Journal
Child Health
Infectious Diseases
Pediatrics
Perinatology
Microbiology
Walking to School and Traffic Exposure in Australian Children
Australian and New Zealand Journal of Public Health
Environmental
Public Health
Occupational Health
Related publications
Antibody Persistence Up to 5 Y After Vaccination With a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine in Adolescents
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Maintenance of Immune Response Throughout Childhood Following Serogroup C Meningococcal Conjugate Vaccination in Early Childhood
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Modelling Cost Effectiveness of Meningococcal Serogroup C Conjugate Vaccination Campaign in England and Wales
BMJ
Persistence of Bactericidal Antibodies Following Early Infant Vaccination With a Serogroup B Meningococcal Vaccine and Immunogenicity of a Preschool Booster Dose
CMAJ
Medicine
Impaired Antibody Response to Conjugated Meningococcal Serogroup C Vaccine in Asplenic Patients
European Journal of Clinical Microbiology and Infectious Diseases
Medicine
Infectious Diseases
Microbiology
Effects of Prior Polysaccharide Vaccination on Magnitude, Duration, and Quality of Immune Responses to and Safety Profile of a Meningococcal Serogroup C Tetanus Toxoid Conjugate Vaccination in Adults
Clinical Diagnostic Laboratory Immunology
Pneumonia Hospitalisations in Scotland Following the Introduction of Pneumococcal Conjugate Vaccination in Young Children
BMC Infectious Diseases
Infectious Diseases
A Licensed Combined Haemophilus Influenzae Type B-Serogroups C and Y Meningococcal Conjugate Vaccine
Infectious Diseases and Therapy
Infectious Diseases
Microbiology
Persistence of Antibody After Subcutaneous Vaccination With Wistar RA 27/3 Rubella Vaccine
Journal of Hygiene
